EUVIMEDEUVIMED entdecken
Open Access

Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023

Erin E Conners, Lakshmi Panagiotakopoulos, Megan G Hofmeister, Philip R Spradling, Liesl M Hagan, Aaron M Harris, Jessica S Rogers-Brown, Carolyn Wester, Noele P Nelson, Contributors

MMWR. Recommendations and Reports · 10.03.2023 · 72 (1) · 1-25

DOI: 10.15585/mmwr.rr7201a1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MMWR. Recommendations and Reports, online erschienen am 10.03.2023. Verfasst von Erin E Conners und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis B, Hepatitis C. Die Arbeit wurde bisher 263-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic hepatitis B virus (HBV) infection can lead to substantial morbidity and mortality. Although treatment is not considered curative, antiviral treatment, monitoring, and liver cancer surveillance can reduce morbidity and mortality. Effective vaccines to prevent hepatitis B are available. This report updates and expands CDC's previously published Recommendations for Identification and Public Health Management of Persons with Chronic Hepatitis B Virus Infection (MMWR Recomm Rep 2008;57[No. RR-8]) regarding screening for HBV infection in the United States. New recommendations include hepatitis B screening using three laboratory tests at least once during a lifetime for adults aged ≥18 years. The report also expands risk-based testing recommendations to include the following populations, activities, exposures, or conditions associated with increased risk for HBV infection: persons incarcerated or formerly incarcerated in a jail, prison, or other detention setting; persons with a history of sexually transmitted infections or multiple sex partners; and persons with a history of hepatitis C virus infection. In addition, to provide increased access to testing, anyone who requests HBV testing should receive it, regardless of disclosure of risk, because many persons might be reluctant to disclose stigmatizing risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicHepatitis BHepatitis CAdultHumansUnited StatesAdolescentHepatitis B virusCenters for Disease Control and Prevention, U.S.

Autor:innen und Institutionen

  • Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC.

Zitieren

APA

Conners, E. E., Panagiotakopoulos, L., Hofmeister, M. G., Spradling, P. R., Hagan, L. M., Harris, A. M., Rogers-Brown, J. S., Wester, C., Nelson, N. P., & Contributors (2023). Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023. MMWR. Recommendations and Reports, 72(1), 1-25. https://doi.org/10.15585/mmwr.rr7201a1

Vancouver

Conners EE, Panagiotakopoulos L, Hofmeister MG, Spradling PR, Hagan LM, Harris AM, et al. Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023. MMWR. Recommendations and Reports. 2023;72(1):1-25. doi:10.15585/mmwr.rr7201a1

BibTeX
@article{Conners2023,
  author = {Conners, Erin E and Panagiotakopoulos, Lakshmi and Hofmeister, Megan G and Spradling, Philip R and Hagan, Liesl M and Harris, Aaron M and Rogers-Brown, Jessica S and Wester, Carolyn and Nelson, Noele P and Contributors, Contributors},
  title = {Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023},
  journal = {MMWR. Recommendations and Reports},
  year = {2023},
  volume = {72},
  number = {1},
  pages = {1--25},
  doi = {10.15585/mmwr.rr7201a1}
}
Kostenlos starten →